Brady James Aloysius 4
4 · Xeris Biopharma Holdings, Inc. · Filed Mar 28, 2025
Insider Transaction Report
Form 4
Brady James Aloysius
Director
Transactions
- Award
Common Stock
2025-03-28+100,000→ 100,000 total
Footnotes (1)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued service on the Company's Board of Directors through such vesting date.